Features

AI can help overcome both scientific and financial hurdles to tackle this serious threat to global health.

Changes in the gut microbiome of infants can induce fear—and possibly anxiety and depression later in life.

SiPhox’s coming silicon photonics technology seems to deliver on at least some of the promises Theranos made.

The biggest shoe design innovation in a decade is great for elite athletes, but maybe not so good for the weekend warrior.

Sarcopenia, a muscle wasting disease, could shorten your life and is alarmingly prevalent. Why are so many people unaware it exists?

Some studies show it’s better than SSRIs—but there’s no incentive to invest in clinical trials.

Featuring pink pineapples, synthetic ice cream, laser skin care, lots of tests, treatments, and of course, books.

A book about shamanic journeys in the backyard and another about the dietary wisdom of roaming herbivores.

How drugs that hit targets for depression and kidney disease could help people suffering physical pain.

Crossing the Atlantic in a 3.5-foot boat is a risky trip that will be punishing on the body. Andrew Bedwell is stoked.

The maniacally focused founder of Insilico Medicine is going all in on AI to discover new medicines and extend lifespan.

A new technique for same sex conception for men raises some tricky questions.

A new generation of scientists raised on Reddit and Instagram are exploring crowdsourced models of scientific peer review.

Humans are forever altering these mythical islands through unnatural selection. Rewilding them entails finding a delicate balance between the needs of turtles, tourists—and local residents.

As organ-on-a-chip technology comes of age, the bipartisan FDA Modernization Act 2.0 would remove the requirement that new drugs must undergo animal testing before human clinical trials.